Circulating miR-103 family as potential biomarkers for type 2 diabetes through targeting CAV-1 and SFRP4.
Mao LuoChunrong XuYulin LuoGang WangJianbo WuQin WanPublished in: Acta diabetologica (2019)
These findings suggest that circulating miR-103a and miR-103b may serve as novel biomarkers for diagnosis of DM2, providing novel insight into the mechanisms underlying pre-DM.